The Indiana University Melvin and Bren Simon Cancer Center (IU Simon Cancer Center) has achieved the highest recognition from the National Cancer Institute (NCI): Comprehensive Cancer Center. With this federal designation signifying research excellence, it becomes the only NCI-designated Comprehensive Cancer Center in Indiana.
Douglas R. Lowy, MD, Acting Director of the National Cancer Institute, shared the news during a celebratory event on the IU School of Medicine campus in Indianapolis. “Designated cancer centers are recognized for their state-of-the-art research programs and strong commitment to delivering cutting-edge cancer treatment for patients. They are at the core of the nation’s cancer research effort,” he said.
Overall, the IU Simon Cancer Center received an “outstanding” rating by NCI reviewers and was awarded a 5-year, $13.8 million grant to support the center’s research programs and shared facilities. That marks an increase of 43% from the previous 5-year funding period.
In addition to recognizing the center’s laboratory and clinical research, reviewers cited the “very well-designed community outreach efforts to serve the needs” of the state of Indiana. These efforts include initiatives to increase human papillomavirus vaccination rates, as well as developing, testing, and disseminating interventions to increase screenings for breast, cervical and colorectal cancers in racially diverse and rural populations in Indiana. ■
